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Background: Associations between the APOE genotype and
various medical conditions have been documented at a very
young age. The association between the APOE genotype and
cognitive performance varies at different ages. APOE related
changes in brain activation have been recently reported for
middle aged and elderly subjects.
Objective: To explore APOE related alterations during
cognitive activation in a population of young adults.
Methods: Using H2
15O positron emission tomography (PET),
imaging was carried out in 20 healthy young adults (age 19
to 28 years; four e4 carriers and 16 non-e4 carriers) during
a non-verbal memory task. Voxel-wise multiple regression
analyses were undertaken, with the activation difference PET
counts as the dependent variable and the APOE genotype as
the independent variable.
Results: Brain regions were identified where e4 carriers
showed significantly lower or higher activation than non-
carriers.
Conclusions: The results suggest that APOE dependent
modulation of cerebral flow may be present even at a young
age. This may reflect an APOE related physiological
heterogeneity which may or may not predispose to brain
disease in the ensuing decades or, less likely, the effect of
very early Alzheimer’s disease related pathological changes.
E
ffects of the APOE genotype on lipid metabolism,1 blood
pressure,2 atherosclerosis,3 ischaemic heart disease,4
myocardial infarction,5 and cognitive performance in
type I diabetes6 have been documented in very young subjects
or even in children.7 8 Animal studies have indicated that the
APOE genotype seems to affect the stress response and
spatial memory9 and to regulate synaptic plasticity and long
term potentiation in the hippocampus10 of young mice. It is
therefore conceivable that APOE related alterations in
cerebral physiology may exist even from a very young age.
Few brain imaging studies have investigated the association
between APOE and patterns of brain activation, and all have
been carried out in middle aged and elderly individuals who
were either cognitively intact11–14 or had Alzheimer’s disease.15
Our group16 and others17 have recently demonstrated APOE
related changes in cerebral flow and metabolism during rest
in very young subjects. We now report APOE related
alterations during cognitive activation in the same popula-
tion.
METHODS
College age right handed healthy young adults (four e4
carriers and 16 non-e4 carriers, reflecting the proportion of
APOE polymorphism in our population) underwent resting
H2
15O positron emission tomography (PET). Subjects were
screened for the absence of any neurological or psychiatric
disease by structured clinical interviews, neuropsychological
testing, and brain magnetic resonance imaging (MRI).
The non-verbal episodic memory task used in the
neuroimaging component of this study (described in more
detail elsewhere18) comprised a simple demand (SD) condi-
tion and a titrated demand (TD) condition (fig 1). For each
scanning session (which included both the encoding and the
recognition phases), a bolus of 30 mCi H2
15O was injected
intravenously. After measured attenuation correction (15
minute transmission scan) and reconstruction by filtered
back projection, image resolution was 4.6 mm full width at
half maximum (FWHM). Non-quantitative counts (referred
to as relative cerebral blood flow (rCBF) values) were
obtained. Eighteen trials for the SD condition and two trials
for the TD condition were acquired during each scan.
Subjects viewed the shape stimuli on an overhead mono-
chrome monitor while lying in a supine position.
The SPM99 program (statistical parametric mapping) was
used to implement realignment, spatial transformation,
smoothing (isotropic, Gaussian kernel (FWHM=12 mm)),
and proportional scaling by global mean. Voxel-wise multiple
regression analyses were carried out with rCBF as the
dependent variable. Independent variables were: the cogni-
tive task condition (TD v SD); the APOE genotype (dichot-
omous form, presence v absence of an e4 allele); and the
cognitive task condition6APOE interaction. Our primary
interest was the statistical significance of the
condition6APOE interaction effect, which relates to the
hypothesis that cerebral activation differs between e4 allele
carriers and non-carriers. Cluster sizes of >10 voxels are
reported. We also report the cognitive task condition effect
(the difference between TD and SD rCBF). This is meant to
represent the cerebral activation related to titrated memory
performance, while subtracting activity related to basic
sensory and motor processing. The false positive rate was
controlled at a=0.05 per map (Bonferroni corrected for
multiple comparisons).
We tested our data for various assumptions of parametric
statistics (PP and QQ plots, Levene’s test for equality of
variances-homoscedasticity, the Kolmogorov–Smirnov test
for normality) and we detected no deviations from the
required assumptions. However, given the small sample size
it is always possible that some of the above tests may fail to
reject the null because of low power and parametric test
assumptions may be still violated. Thus to allow for possible
non-normality in the distribution of the activation mean of
the e4 carriers, we conducted a random permutation test
(which in contrast to parametric tests, does not require any
distributional assumptions) at the voxels where the para-
metric SPM analysis produced significant results.
Abbreviations: APOE, apolipoprotein E; FWHM, full width at half
maximum; rCBF, relative cerebral blood flow; SD, simple demand; SPM,
statistical parametric mapping; TD, titrated demand
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MNI coordinates were converted to standard Talairach
brain atlas coordinates. A search for the closest grey matter
Brodmann areas was carried out using the ‘‘Talairach
Demon’’ database server http://biad02.uthscsa.edu/RIC_
WWW.data/Components/talairach/talairachdaemon.html.
RESULTS
Age, education, and neuropsychological performance did not
differ among the groups (table 1). There was no association
between APOE genotype and ethnicity: e4 carriers, three
white and one African American; non-e4 carriers, 11 white,
one African American, one Hispanic, and three other
ethnicities (x2 = 2.1, p=0.54). All e4 carriers and seven
non-e4 carriers were male (p=0.09, Fisher’s exact test).
Neither shape recognition accuracy nor shape list length were
related to the APOE genotype.
In comparison with the subjects without the e4 allele, e4
carriers showed significant deactivation in right superior
temporal and left fusiform gyri (table 2, fig 2, fig 3). E4
carriers showed significantly higher activation in the left
middle temporal and right transverse temporal gyri (table 2,
fig 2, fig 3). The results were also significant in the non-
parametric test. Because of the slight (although non-
significant) imbalance in sex distribution, we conducted
supplementary analyses including sex as a covariate; the
results were essentially unchanged.
For all 20 subjects combined there were significant
activations (t values ranging from 4.51 to 8.11) during the
TD as compared to the SD condition in bilateral occipital-
parietal areas (Brodmann areas (BA) 18, 19; middle occipital
gyri, cuneus and fusiform gyri), right inferior parietal lobule
(BA 40), right inferior (BA 9), and left superior (BA 10) and
middle frontal (BA 9) gyri. Significant deactivations (t values
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Figure 1 Non-verbal memory task. During the simple demand (SD) condition a single shape (the same each time) was presented during the encoding
phase, followed by one shape during the recognition phase (either the same as the encoding phase shape or a non-familiar foil). The titrated demand
(TD) condition involved a serial presentation of a sequence of shapes during the encoding phase; the length of the sequence was determined in a
training session on the day preceding the PET scan during which shape list size was adjusted in a staircase manner such that recognition accuracy of
about 75% for each individual subject was attained; the recognition phase of the TD condition involved presentation of shapes studied during the
preceding encoding phase intermixed with non-familiar foils. For presentation purposes, a list length of three shapes during the TD condition is
illustrated here. During the recognition phases of both SD and TD conditions subjects were instructed to make a ‘‘new’’ or ‘‘old’’ response for each
probe item (distinguished from encoding items by a rectangular frame) by pressing one of two microswitches. ‘‘New’’ and ‘‘old’’ test probes each
occurred with a frequency of 50%. Test probes were pseudorandomised so that no more than four consecutive trials required the same response. Each
shape was used only once for each subject.
Table 1 Demographic and neuropsychological performance information by APOE group
No e4 allele e2/e3 (n = 2), e3/e3 (n = 14) Presence of e4 allele e3/e4 (n = 4)
p ValueMean (SD) Range Mean (SD) Range
Age (years) 23.1 (2.25) 19 to 28 25.3 (1.23) 24 to 27 0.09
Education (years) 16.8 (1.83) 13 to 20 17.0 (2.45) 14 to 19 0.87
mMMS 55.6 (1.03) 53 to 57 56.0 (1.41) 54 to 57 0.55
NART IQ 120.8 (3.19) 115.2 to 126.6 122.3 (4.64) 115.8 to 125.7 0.47
WAIS-R vocabulary 13.6 (1.37) 10 to 15 12.5 (2.38) 9 to 14 0.25
SRT total recall 59.1 (6.31) 49 to 69 55.0 (8.83) 43 to 63 0.29
SRT delayed recall 10.4 (1.50) 7 to 12 9.5 (1.73) 8 to 11 0.29
WAIS-R digit symbol 12.5 (2.94) 6 to 19 10.8 (4.27) 5 to 14 0.34
Recognition accuracy (% of shapes) 0.81 (0.11) 0.55 to 0.95 0.79 (0.13) 0.61 to 0.92 0.77
TD shape list length 14.9 (6.69) 5 to 35 14.8 (4.92) 10 to 19 0.96
Student’s t test was used for p value calculations.
mMMS, modified mini-mental state examination; NART IQ, Nelson adult reading test IQ; SRT, selective reminding test; TD, titrated demand; WAIS-R, Wechsler
adult intelligence scale–revised.
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4.69 to 14.15) during the TD (as compared to SD) condition
were noted in the anterior cingulate area (BA 32), bilateral
temporal areas (BA 21, 22, 39; superior and middle temporal
gyri), bilateral parietal areas (BA 40, 39; inferior parietal
lobule and angular gyrus), bilateral insula (BA 13), bilateral
frontal (BA 11, 9, 47; medial, middle and inferior frontal
gyri), left fusiform, and lingual gyri (BA 20, 18), and
putamen. There was no overlap between the above areas
and regions where the cognitive task condition6APOE
interaction was significant.
DISCUSSION
We observed differences in brain activation in healthy young
subjects with different APOE genotypes. College age healthy
e4 carriers, although cognitively indistinguishable from non-
e4 carriers, showed areas of significantly different activation
(either higher or lower) during the non-verbal memory task.
These differences were not a reflection of task difficulty
(which was equated in our experimental design) but indicate
memory related altered cerebral physiology in young subjects
with the e4 allele.
There are known early biochemical changes in neuronal
processes and synapses, long before structural Alzheimer’s
disease pathology is detected.19 It is conceivable that these
changes may be manifested in rCBF activation studies. It is
also known that symptoms of Alzheimer’s disease are
preceded by a period of unknown duration during which
neuropathological alterations accumulate in the brain with-
out associated memory loss or other detectable cognitive
change. In a neuropathological study of 105 necropsy cases
who showed no signs of dementia, abnormally high brain b
amyloid levels were reported for e4 carriers as young as 40
years of age.20 That study concluded that the e4 allele
predisposes the carriers to begin accumulating b amyloid
earlier in life than non-carriers. In another study, the e4 allele
was associated with the presence of neurofibrillary tangle
changes in 44 necropsy cases of young subjects (mean age 38
years, range 22 to 46).21 The usual pattern seen in PET
imaging of Alzheimer patients includes parietal, temporal,
cingulate, and sometimes prefrontal hypometabolism or
hypoperfusion.22–26 The e4 related differences in activation
were localised in the temporal areas in our study. Thus
incipient Alzheimer’s disease type pathology may be present
in e4 carriers even from a very young age, while the brain
preserves enough redundancy/efficiency to avoid failure in
clinical cognitive performance.
However, several considerations make this possibility less
plausible. The fact that the APOE related differences in
activation are detected at such a young age (four to five
decades before the possible onset of dementia) weakens the
hypothesised link with Alzheimer’s disease. The spatial
extend of differences in activation between e4 carriers and
non-carriers is small and both increased and decreased
activation was noted for e4 carriers. Most resting flow or
metabolism studies have reported decreased signal at parietal
association areas but we did not detect differences in this
location. The e4 allele’s presence is not equivalent to early
Alzheimer’s disease, and a significant proportion of e4
heterozygotes will never develop Alzheimer’s disease. It has
been proposed that e4 facilitates rather than causes the
disorder27 and e4 has been implicated in impaired brain repair
mechanisms which may place subjects at risk for either
Alzheimer’s disease or other brain diseases. Important direct
effects of the e4 allele on the nervous system include
impaired neuroregeneration within the dentate gyrus28 and
increased vulnerability to exogenous neurotoxins.29 The
Table 2 Areas where significant associations between brain activation differences (TD – SD) and APOE (presence versus





(voxels) Location (Brodmann’s area)x y z
Areas where e4 carriers
showed lower rCBF activation
53 10 210 5.5 24 Right superior temporal gyrus (38)
253 236 227 5.3 20 Left inferior temporal-fusiform gyrus (20)
Areas where e4 carriers
showed higher rCBF activation
242 256 24 5.6 12 Left middle temporal gyrus (37)
36 231 11 5.3 18 Right transverse temporal gyrus (41)
rCBF, relative cerebral blood flow.
Figure 2 Three dimensional brain rendering representation of
statistical parametric mapping depicting areas of significant mean brain
activation (p,0.05, Bonferroni corrected): relative cerebral blood flow
differences (titrated demand minus simple demand) between subjects
with and without an e4 allele.
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observed activation pattern of e4 carriers in their twenties
may be the early signature of an APOE dependent alteration
in brain physiology which could result in greater vulnerability
to environmental effects (such as traumatic brain injury or
other insult) later in life. It is also conceivable that
differences in cerebral activation may not be strictly APOE
related but may be present as a function of many neurally
expressed genes other than APOE. Thus the detected
activation differences may reflect an APOE dependent
physiological heterogeneity which may not necessarily lead
to disease.
In PET studies during rest, the inheritance of the e4 allele
has been associated with decreased parietal,30 31 temporal,
cingulate, and prefrontal31 metabolism (as with the PET
pattern seen in Alzheimer’s disease) in middle aged adults
with a family history of Alzheimer’s disease. Resting imaging
studies in young people have revealed decreased temporal,16
parietal, cingulate, and prefrontal17 metabolism or perfusion,
but also increased insula, supramarginal, and superior
occipital gyral16 perfusion for the e4 carriers. All detected
differences in activation in our study were localised to the
temporal regions where alterations in resting metabolism or
flow have been noted for both middle aged and young e4
carriers.
Only four previous studies have investigated APOE related
brain activation, with mixed results. One study reported
increases in the extent and intensity of activation during
learning and recall periods in (among other regions)
temporal areas in middle aged and elderly e4 allele carriers,12
which was interpreted as an attempt to ameliorate the effects
of reduced function in the networks that normally operate
during the task. We also noted increased activation for the e4
carriers in temporal areas. However, unlike the above study,
we also found areas of decreased activation for the e4
carriers. Decreased activation for e4 carriers has been
reported in two other studies—one of middle aged women
with at least one first degree relative with Alzheimer’s disease
during a letter fluency task14 32 and one of cognitively intact
elderly people while performing the same non-verbal
memory task.11 As compared with the above two studies,
the locations of decreased activation in the present study
were less extended and spatially close (but not identical).
Previously reported increased activations for e4 carriers in
prefrontal12 or parietal areas12 14 were not noted in our study.
In contrast to previous reports, no APOE related differences
were detected in another study of elderly subjects using a
verbal working memory task at various levels of task
difficulty.13 The investigators concluded that the effect of
APOE is specific to episodic encoding and not related to
general task difficulty. We detected APOE related differences
in our study despite having titrated shape list length, which
supports the above notion that the association between APOE
genotype and cerebral activation does not seem to be equated
to task difficulty.
Many factors may account for discrepancies in the findings
between the present and previous activation studies: differ-
ent imaging modes (all but one previous studies used BOLD-
fMRI, where the signal is the result of a complex interaction
between changes not only of blood flow but also of blood
volume and oxygen consumption accompanying neural
activity), differences in power (more spatially restricted
activations or deactivations in the current study may be the
result of fewer subjects or different relative proportions of
















































































































































Figure 3 Graphs plotting relative
cerebral blood flow (rCBF) activation
(TD2SD) for the two groups. Note the
almost clear rCBF separation between
the e4 carriers and non-carriers in these
regions. In the right transverse temporal
gyrus there is a visual impression of
three (rather than four) e4 carriers
because of close proximity of rCBF
values.
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populations studied (demographics, ethnicity, neuropsycho-
logical performance, family history of Alzheimer’s disease,
recruitment methods, and so on). In particular, all previous
studies have been done in middle aged or elderly people. Also
the present study equated for task difficulty, an experimental
design not used in previous studies (activation differences
have to be considered under the factor of increased task
complexity, because activations may reflect modulation of
the same network in response to differential difficulty rather
than APOE related recruitment). Finally, cognitive activation
tasks have differed across studies. Previous cognitive tasks
have included a verbal fluency test,14 a covert object naming
test,32 a paired associates verbal recall test,12 and a digit span
working memory task.13 The present task is likely to make
demands on episodic memory encoding, storage, and
retrieval but also frontoparietal networks underlying shifts
of spatial attention.33–35
This is the first report indicating that e4 allele carriers have
alterations in brain activation even at very young age when
behavioural, cognitive, or clinical evidence of disease is
absent. Although the results were similar in a sex adjusted
model, the absence of sex matching could be a confounding
factor. Because of the relatively small number of participants
(in particular for the e4 group) the results can only be viewed
as preliminary and they should be confirmed in a larger
study. However, the significant associations noted indicate
that there were effects strong enough to be demonstrable
even with our conservative approach to type I error.
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